Easterly Investment Partners LLC Raises Stock Holdings in Quanterix Co. (NASDAQ:QTRX)

Easterly Investment Partners LLC boosted its stake in shares of Quanterix Co. (NASDAQ:QTRX) by 9.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 954,995 shares of the company’s stock after buying an additional 78,862 shares during the quarter. Easterly Investment Partners LLC owned 2.48% of Quanterix worth $10,152,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Portolan Capital Management LLC lifted its stake in Quanterix by 31.4% during the third quarter. Portolan Capital Management LLC now owns 2,520,686 shares of the company’s stock worth $32,668,000 after purchasing an additional 602,656 shares in the last quarter. Vanguard Group Inc. grew its position in Quanterix by 0.9% in the 4th quarter. Vanguard Group Inc. now owns 2,217,225 shares of the company’s stock valued at $23,569,000 after acquiring an additional 19,386 shares in the last quarter. William Blair Investment Management LLC purchased a new stake in Quanterix during the fourth quarter worth about $11,290,000. Geode Capital Management LLC lifted its position in shares of Quanterix by 2.2% during the third quarter. Geode Capital Management LLC now owns 858,667 shares of the company’s stock worth $11,131,000 after purchasing an additional 18,231 shares in the last quarter. Finally, State Street Corp boosted its stake in shares of Quanterix by 2.2% in the third quarter. State Street Corp now owns 836,443 shares of the company’s stock valued at $10,840,000 after purchasing an additional 18,050 shares during the period. 86.48% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently weighed in on QTRX shares. Canaccord Genuity Group cut their target price on shares of Quanterix from $20.00 to $15.00 and set a “buy” rating on the stock in a research note on Tuesday, March 18th. Scotiabank reaffirmed an “outperform” rating on shares of Quanterix in a research report on Tuesday.

Quanterix Stock Down 5.1 %

Shares of NASDAQ:QTRX opened at $6.66 on Thursday. Quanterix Co. has a fifty-two week low of $6.30 and a fifty-two week high of $23.94. The stock has a market cap of $258.25 million, a price-to-earnings ratio of -6.28 and a beta of 1.33. The firm’s 50 day moving average price is $8.08 and its 200 day moving average price is $10.72.

Quanterix (NASDAQ:QTRX) last released its quarterly earnings data on Monday, March 17th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.03). The firm had revenue of $35.16 million for the quarter, compared to analysts’ expectations of $34.93 million. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. On average, equities analysts anticipate that Quanterix Co. will post -0.98 EPS for the current year.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.